198 related articles for article (PubMed ID: 29885843)
1. LRP4 promotes proliferation, migration, and invasion in papillary thyroid cancer.
Zhou X; Xia E; Bhandari A; Zheng C; Xiang J; Guan Y; Zhang X
Biochem Biophys Res Commun; 2018 Sep; 503(1):257-263. PubMed ID: 29885843
[TBL] [Abstract][Full Text] [Related]
2. The lncRNA UNC5B-AS1 promotes proliferation, migration, and invasion in papillary thyroid cancer cell lines.
Wang Y; Bhandari A; Niu J; Yang F; Xia E; Yao Z; Jin Y; Zheng Z; Lv S; Wang O
Hum Cell; 2019 Jul; 32(3):334-342. PubMed ID: 30805847
[TBL] [Abstract][Full Text] [Related]
3. Growth-associated protein 43 promotes thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Quan RD; Wu CY; Hu J; Lin BY; Dong XB; Xia EJ; Bhandari A; Zhang XH; Wang OC
J Cell Mol Med; 2019 Dec; 23(12):7974-7984. PubMed ID: 31568662
[TBL] [Abstract][Full Text] [Related]
4. Downregulating integrin subunit alpha 7 (ITGA7) promotes proliferation, invasion, and migration of papillary thyroid carcinoma cells through regulating epithelial-to-mesenchymal transition.
Guan Y; Bhandari A; Xia E; Kong L; Zhang X; Wang O
Acta Biochim Biophys Sin (Shanghai); 2020 Feb; 52(2):116-124. PubMed ID: 31942970
[TBL] [Abstract][Full Text] [Related]
5. TEKT4 Promotes Papillary Thyroid Cancer Cell Proliferation, Colony Formation, and Metastasis through Activating PI3K/Akt Pathway.
Zheng Z; Zhou X; Cai Y; Chen E; Zhang X; Wang O; Wang Q; Liu H
Endocr Pathol; 2018 Dec; 29(4):310-316. PubMed ID: 30251060
[TBL] [Abstract][Full Text] [Related]
6. EZH2 upregulation by ERα induces proliferation and migration of papillary thyroid carcinoma.
Xue L; Yan H; Chen Y; Zhang Q; Xie X; Ding X; Wang X; Qian Z; Xiao F; Song Z; Wu Y; Peng Y; Xu H
BMC Cancer; 2019 Nov; 19(1):1094. PubMed ID: 31718595
[TBL] [Abstract][Full Text] [Related]
7. LncRNA CCND2-AS1 promotes proliferation, migration, and invasion in papillary thyroid carcinoma.
Xia E; Bhandari A; Shen Y; Zhou X; Sindan N; Xiang J; Guan Y; Yang F; Wang O
Biochem Biophys Res Commun; 2018 Feb; 496(2):628-632. PubMed ID: 29366479
[TBL] [Abstract][Full Text] [Related]
8. LncRNA LINC00673 inhibits p53 expression by interacting with EZH2 and DNMT1 in papillary thyroid carcinoma.
Meng XF; Zhao LY; Chu XF
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2075-2083. PubMed ID: 30915752
[TBL] [Abstract][Full Text] [Related]
9. MicroRNA-222 Promotes Invasion and Metastasis of Papillary Thyroid Cancer Through Targeting Protein Phosphatase 2 Regulatory Subunit B Alpha Expression.
Huang Y; Yu S; Cao S; Yin Y; Hong S; Guan H; Li Y; Xiao H
Thyroid; 2018 Sep; 28(9):1162-1173. PubMed ID: 29882471
[TBL] [Abstract][Full Text] [Related]
10. Has_circ_0008274 promotes cell proliferation and invasion involving AMPK/mTOR signaling pathway in papillary thyroid carcinoma.
Zhou GK; Zhang GY; Yuan ZN; Pei R; Liu DM
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8772-8780. PubMed ID: 30575918
[TBL] [Abstract][Full Text] [Related]
11. GABRB2 plays an important role in the lymph node metastasis of papillary thyroid cancer.
Jin Y; Jin W; Zheng Z; Chen E; Wang Q; Wang Y; Wang O; Zhang X
Biochem Biophys Res Commun; 2017 Oct; 492(3):323-330. PubMed ID: 28859983
[TBL] [Abstract][Full Text] [Related]
12. Scavenger receptor class A, member 5 is associated with thyroid cancer cell lines progression via epithelial-mesenchymal transition.
Zheng C; Xia EJ; Quan RD; Bhandari A; Wang OC; Hao RT
Cell Biochem Funct; 2020 Mar; 38(2):158-166. PubMed ID: 31989658
[TBL] [Abstract][Full Text] [Related]
13. Podoplanin (PDPN) affects the invasiveness of thyroid carcinoma cells by inducing ezrin, radixin and moesin (E/R/M) phosphorylation in association with matrix metalloproteinases.
Sikorska J; Gaweł D; Domek H; Rudzińska M; Czarnocka B
BMC Cancer; 2019 Jan; 19(1):85. PubMed ID: 30654768
[TBL] [Abstract][Full Text] [Related]
14. LncRNA RGMB-AS1 is activated by E2F1 and promotes cell proliferation and invasion in papillary thyroid carcinoma.
Zhang Z; Li SY; Zhang LB
Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):1979-1986. PubMed ID: 29687852
[TBL] [Abstract][Full Text] [Related]
15. LRRC52-AS1 is associated with clinical progression and regulates cell migration and invasion in papillary thyroid cancer.
Zhou Y; Xiang J; Bhandari A; Wen J; Lin B; Kong L; Wang O
Clin Exp Pharmacol Physiol; 2020 Apr; 47(4):696-702. PubMed ID: 31855284
[TBL] [Abstract][Full Text] [Related]
16. ALDH5A1 acts as a tumour promoter and has a prognostic impact in papillary thyroid carcinoma.
Deng XY; Gan XX; Feng JH; Cai WS; Wang XQ; Shen L; Luo HT; Chen Z; Guo M; Cao J; Shen F; Xu B
Cell Biochem Funct; 2021 Mar; 39(2):317-325. PubMed ID: 32881051
[TBL] [Abstract][Full Text] [Related]
17. Overexpressed ZC3H13 suppresses papillary thyroid carcinoma growth through m6A modification-mediated IQGAP1 degradation.
Xie R; Chen W; Lv Y; Xu D; Huang D; Zhou T; Zhang S; Xiong C; Yu J
J Formos Med Assoc; 2023 Aug; 122(8):738-746. PubMed ID: 36739231
[TBL] [Abstract][Full Text] [Related]
18. Role of Lin28A/let-7a/c-Myc Pathway in Growth and Malignant Behavior of Papillary Thyroid Carcinoma.
Huang J; Lin H; Zhong M; Huang J; Sun S; Lin L; Chen Y
Med Sci Monit; 2018 Dec; 24():8899-8909. PubMed ID: 30531691
[TBL] [Abstract][Full Text] [Related]
19. TFE3 Regulates the Function of the Autophagy-Lysosome Pathway to Drive the Invasion and Metastasis of Papillary Thyroid Carcinoma.
Lu H; Zhu C; Ruan Y; Fan L; Wei K; Yang Z; Chen Q
Anal Cell Pathol (Amst); 2021; 2021():3081491. PubMed ID: 34660181
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of TSPAN13 by miR-369-3p inhibits cell proliferation in papillary thyroid cancer (PTC).
Li P; Dong M; Wang Z
Bosn J Basic Med Sci; 2019 May; 19(2):146-154. PubMed ID: 30114378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
